Fisker Inc./DE

2023 Q2 Form 10-Q Financial Statement

#000172099023000089 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022 Q2

Balance Sheet

Concept 2023 Q2 2022 Q4 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $470.3M $739.7M $857.0M
YoY Change -45.12% -38.48% -10.95%
Cash & Equivalents $467.5M $736.5M $852.0M
Short-Term Investments $2.750M $3.140M $5.090M
Other Short-Term Assets $169.5M $63.84M $39.61M
YoY Change 327.85% 109.83% 67.08%
Inventory $173.0M $4.276M
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $846.2M $831.5M $896.6M
YoY Change -5.63% -32.56% -9.07%
LONG-TERM ASSETS
Property, Plant & Equipment $539.7M $387.1M $177.9M
YoY Change 203.35% 352.04% 652.66%
Goodwill
YoY Change
Intangibles $236.9M $246.9M $244.9M
YoY Change -3.27% 6.65%
Long-Term Investments
YoY Change
Other Assets $54.44M $16.49M $42.10M
YoY Change 29.29% -33.07% 3068.1%
Total Long-Term Assets $884.1M $684.0M $492.3M
YoY Change 79.59% 89.94% 139.7%
TOTAL ASSETS
Total Short-Term Assets $846.2M $831.5M $896.6M
Total Long-Term Assets $884.1M $684.0M $492.3M
Total Assets $1.730B $1.515B $1.389B
YoY Change 24.58% -4.87% 16.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $183.3M $58.87M $22.59M
YoY Change 711.33% 109.19% -25.73%
Accrued Expenses $393.7M $264.9M $56.83M
YoY Change 592.77% 232.68% 97.21%
Deferred Revenue $4.900M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $586.2M $330.9M $85.23M
YoY Change 587.82% 194.56% 43.88%
LONG-TERM LIABILITIES
Long-Term Debt $661.7M $660.8M $660.0M
YoY Change 0.26% 0.22%
Other Long-Term Liabilities $57.97M $43.22M $37.37M
YoY Change 55.13% 103.55% 72.75%
Total Long-Term Liabilities $719.6M $704.0M $697.3M
YoY Change 3.2% 3.45% 3123.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $586.2M $330.9M $85.23M
Total Long-Term Liabilities $719.6M $704.0M $697.3M
Total Liabilities $1.306B $1.035B $782.6M
YoY Change 66.87% 30.52% 867.76%
SHAREHOLDERS EQUITY
Retained Earnings -$1.400B -$1.200B -$847.0M
YoY Change 65.29% 93.78%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $424.4M $480.5M $606.4M
YoY Change
Total Liabilities & Shareholders Equity $1.730B $1.515B $1.389B
YoY Change 24.58% -4.87% 16.57%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 fsr Convertible Senior Notes Noncurrent
ConvertibleSeniorNotesNoncurrent
661683000 usd
CY2022Q4 fsr Convertible Senior Notes Noncurrent
ConvertibleSeniorNotesNoncurrent
660822000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
719648000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
704040000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1305861000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1034921000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1794327000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1650196000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1369903000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1166741000 usd
CY2023Q2 fsr Receivable For Stock Issuance
ReceivableForStockIssuance
0 usd
CY2022Q4 fsr Receivable For Stock Issuance
ReceivableForStockIssuance
2953000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424427000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480505000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1730288000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1515426000 usd
CY2023Q2 us-gaap Revenues
Revenues
825000 usd
CY2022Q2 us-gaap Revenues
Revenues
10000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
760000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
8000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
65000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42267000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17521000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45982000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71160000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
88249000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
88681000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-88184000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-88679000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-260000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-452000 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
6581000 usd
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1353000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
4605000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
4751000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3800000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3417000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
340000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-10030000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5856000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17297000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6973000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15920000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82328000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-105976000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202824000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-228050000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
279000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
338000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-82607000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-105976000 usd
us-gaap Net Income Loss
NetIncomeLoss
-203162000 usd
us-gaap Net Income Loss
NetIncomeLoss
-228050000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335888051 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335888051 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
298269801 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
298269801 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
328494512 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328494512 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
297558618 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
297558618 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
407690000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9026000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3770000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
86542000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-82607000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424427000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
480505000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7384000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6000000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
133674000 usd
us-gaap Net Income Loss
NetIncomeLoss
-203162000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424427000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
690026000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1195000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
216000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6694000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14215000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-105976000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
606370000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
800042000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6260000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
514000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
13389000 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1388151 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14215000 usd
us-gaap Net Income Loss
NetIncomeLoss
-228050000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
606370000 usd
us-gaap Profit Loss
ProfitLoss
-203162000 usd
us-gaap Profit Loss
ProfitLoss
-228050000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7384000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6260000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
26234000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
584000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3418000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2043000 usd
fsr Accretion Of Debt Issuance Costs
AccretionOfDebtIssuanceCosts
861000 usd
fsr Accretion Of Debt Issuance Costs
AccretionOfDebtIssuanceCosts
625000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4454000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
166536000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
99107000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26655000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
229281000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25547000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-24000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8150000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6094000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1866000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-211809000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-255468000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137062000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
99911000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-137062000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-109911000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2794000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2079000 usd
fsr Payments For Redemption Of Unexercised Warrants
PaymentsForRedemptionOfUnexercisedWarrants
0 usd
fsr Payments For Redemption Of Unexercised Warrants
PaymentsForRedemptionOfUnexercisedWarrants
134000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2768000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1415000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
135928000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14568000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1850000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
219000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134104000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14879000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-214767000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-350500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
736549000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1202439000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
521782000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
851939000 usd
us-gaap Interest Paid Net
InterestPaidNet
8344000 usd
us-gaap Interest Paid Net
InterestPaidNet
9642000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
106000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
467500000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1400000000 usd
fsr Number Of Battery Solutions
NumberOfBatterySolutions
2 battery_solution
fsr Number Of Battery Capacity Gigawatt Hours
NumberOfBatteryCapacityGigawattHours
5 gwh
us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP required management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the condensed consolidated financial statements and accompanying notes. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates.
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
54200000 usd
CY2022Q3 fsr Translation Adjustment Functional To Reporting Currency Purchase Of Foreign Currency
TranslationAdjustmentFunctionalToReportingCurrencyPurchaseOfForeignCurrency
130100000 eur
CY2022Q2 fsr Translation Adjustment Functional To Reporting Currency Purchase Of Foreign Currency
TranslationAdjustmentFunctionalToReportingCurrencyPurchaseOfForeignCurrency
130100000 eur
CY2022Q3 fsr Translation Adjustment Functional To Reporting Currency Purchase Of Foreign Currency
TranslationAdjustmentFunctionalToReportingCurrencyPurchaseOfForeignCurrency
140000000.0 usd
CY2022Q2 fsr Translation Adjustment Functional To Reporting Currency Purchase Of Foreign Currency
TranslationAdjustmentFunctionalToReportingCurrencyPurchaseOfForeignCurrency
140000000.0 usd
CY2022Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.076
CY2022Q3 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
50000000.0 eur
CY2022Q2 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
50000000.0 eur
CY2022Q3 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
50900000 usd
CY2022Q2 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
50900000 usd
CY2022Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.018
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
391793000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
604185000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
300000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-400000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
109090000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
698000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
61886000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2020000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3578000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
172996000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4276000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
1100000 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q2 fsr Prepaid Advanced Payments To Suppliers
PrepaidAdvancedPaymentsToSuppliers
57198000 usd
CY2022Q4 fsr Prepaid Advanced Payments To Suppliers
PrepaidAdvancedPaymentsToSuppliers
27218000 usd
CY2023Q2 fsr Prepaid Value Added Tax Receivable
PrepaidValueAddedTaxReceivable
33408000 usd
CY2022Q4 fsr Prepaid Value Added Tax Receivable
PrepaidValueAddedTaxReceivable
27928000 usd
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
10312000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2951000 usd
CY2023Q2 fsr Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
47732000 usd
CY2022Q4 fsr Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
29392000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
148650000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
87489000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
258304000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21408000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
236896000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
252304000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5382000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
246922000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8200000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16200000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
32300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
32300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
32300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
32300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
32300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
32300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
552357000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
389618000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12615000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2481000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
539742000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387137000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
11600000 usd
us-gaap Depreciation
Depreciation
12900000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
400000 usd
us-gaap Depreciation
Depreciation
600000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
172800000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
144800000 usd
fsr Non Cash Operating Lease Right Of Use Assets
NonCashOperatingLeaseRightOfUseAssets
21400000 usd
CY2022 fsr Non Cash Operating Lease Right Of Use Assets
NonCashOperatingLeaseRightOfUseAssets
33400000 usd
fsr Non Cash Operating Lease Liability
NonCashOperatingLeaseLiability
19100000 usd
CY2022 fsr Non Cash Operating Lease Liability
NonCashOperatingLeaseLiability
35000000.0 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53037000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33424000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9251000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7085000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42655000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27884000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2128000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1153000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
20000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
61000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
2148000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
1214000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
4958000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
2525000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
179000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
117000 usd
us-gaap Lease Cost
LeaseCost
5137000 usd
us-gaap Lease Cost
LeaseCost
2642000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0799
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0527
us-gaap Operating Lease Payments
OperatingLeasePayments
4050000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2353000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21432000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11065000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6309000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12945000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11710000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10750000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6653000 usd
CY2023Q2 fsr Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
16072000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
64439000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12533000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
51906000 usd
fsr Finance Lease Right Of Use Asset At Lease Inception
FinanceLeaseRightOfUseAssetAtLeaseInception
24600000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
12700000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000 usd
CY2023Q2 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P8Y
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
26000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
393683000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264925000 usd
CY2022Q3 fsr Prepayment Amount For Fisker Ocean Ones
PrepaymentAmountForFiskerOceanOnes
5000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12900000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15310000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15334000 usd
CY2023Q2 fsr Customer Deposit Reservation Deposit Amount
CustomerDepositReservationDepositAmount
250000 usd
CY2020Q4 fsr Number Of Milestone Performance Conditions
NumberOfMilestonePerformanceConditions
3 milestone
CY2020Q4 fsr Class Of Warrant Or Right Number Of Warrants That Vest Upon Milestone Achievement Shares
ClassOfWarrantOrRightNumberOfWarrantsThatVestUponMilestoneAchievementShares
19474454 shares
CY2023Q2 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
174297000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
174297000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-82607000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-105976000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335888051 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335888051 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
298269801 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
298269801 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Net Income Loss
NetIncomeLoss
-203162000 usd
us-gaap Net Income Loss
NetIncomeLoss
-228050000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328494512 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
328494512 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
297558618 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
297558618 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
70828587 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
64453024 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9026000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1195000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7384000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6260000 usd
fsr Minimum Estimated Fair Value Percentage Of Exercise Price On Date Of Grant
MinimumEstimatedFairValuePercentageOfExercisePriceOnDateOfGrant
1
fsr Minimum Percentage Of Shareholders
MinimumPercentageOfShareholders
0.10
fsr Estimated Fair Value Percentage Of Exercise Price On Date Of Grant
EstimatedFairValuePercentageOfExercisePriceOnDateOfGrant
1.10
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17679596 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.51
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.05
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
58151 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
58151 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.45
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
166157 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
166157 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.44
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.44
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17462288 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.41
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.745
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.752
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0340
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0400
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001720990-23-000089-index-headers.html Edgar Link pending
0001720990-23-000089-index.html Edgar Link pending
0001720990-23-000089.txt Edgar Link pending
0001720990-23-000089-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fsr-20230630.htm Edgar Link pending
fsr-20230630.xsd Edgar Link pending
fsr-20230630_g1.jpg Edgar Link pending
fsr20230809-10qex321.htm Edgar Link pending
fsr2023080910-qex311.htm Edgar Link pending
fsr2023080910-qex312.htm Edgar Link pending
fsr2023080910-qex322.htm Edgar Link pending
fsr2023080910-qex991.htm Edgar Link pending
fsr2023080910-qex992.htm Edgar Link pending
image_0a.jpg Edgar Link pending
image_1a.jpg Edgar Link pending
image_4a.jpg Edgar Link pending
image_5a.jpg Edgar Link pending
image_7a.jpg Edgar Link pending
image_8a.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fsr-20230630_cal.xml Edgar Link unprocessable
fsr-20230630_lab.xml Edgar Link unprocessable
fsr-20230630_pre.xml Edgar Link unprocessable
fsr-20230630_htm.xml Edgar Link completed
image_9a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fsr-20230630_def.xml Edgar Link unprocessable